RAGE-NF-κB pathway activation in response to oxidative stress in facioscapulohumeral muscular dystrophy

Acta Neurologica Scandinavica

Volumn 115, Issue 2, 2007, Pages 115-121

  Macaione, V ^a,d   Aguennouz, M ^a   Rodolico, C ^a   Mazzeo, A ^a   Patti, A ^b   Cannistraci, E ^a   Colantone, L ^c   Di Giorgio, R M ^a   De Luca, G ^a   Vita, G ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF CATANIA   (Italy)

^c UILDM   (Italy)

^d UNIVERSITY OF MESSINA   (Italy)

Author keywords

ANT1; FSHD; NF B; Oxidative stress; RAGE; Reactive oxygen species

Indexed keywords

ADENINE NUCLEOTIDE TRANSLOCASE; GLUTATHIONE PEROXIDASE; HYDROGEN PEROXIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PEROXIDASE; ADVANCED GLYCOSYLATION END PRODUCT RECEPTOR; ADVANCED GLYCOSYLATION END-PRODUCT RECEPTOR; IMMUNOGLOBULIN RECEPTOR; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ARTICLE; BINDING AFFINITY; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; DNA BINDING; DUCHENNE MUSCULAR DYSTROPHY; ENZYME ACTIVITY; FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY; FEMALE; GEL MOBILITY SHIFT ASSAY; GLYCATION; HUMAN; IMMUNOCYTOCHEMISTRY; MALE; MUSCLE; OXIDATIVE STRESS; PATHOGENESIS; PROTEIN EXPRESSION; SAMPLE; WESTERN BLOTTING; CASE CONTROL STUDY; METABOLISM; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY; PRESCHOOL CHILD; SKELETAL MUSCLE;

ADENINE NUCLEOTIDE TRANSLOCATOR 1; ADOLESCENT; ADULT; AGED; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MUSCLE, SKELETAL; MUSCULAR DYSTROPHY, FACIOSCAPULOHUMERAL; NF-KAPPA B; OXIDATIVE STRESS; RECEPTORS, IMMUNOLOGIC;

EID: 33845880871     PISSN: 00016314     EISSN: 16000404     Source Type: Journal    
DOI: 10.1111/j.1600-0404.2006.00724.x     Document Type: Article

References (27)

1. PADBERG GW, ADAMS C. Facioscapulohumeral dystrophy. In: Pulst S-M, ed. Neurogenetics. New York: Oxford University Press, 2000;105-15.
2. ARAHATA K, ISHIHARA T, FUKUNAGA H et al. Inflammatory response in facioscapulohumeral muscular dystrophy (FSHD): immunocytochemical and genetic analyses. Muscle Nerve 1995;2:56-66.
3. VAN DEUTEKOM JT, WIJMENGA C, VAN TIENHOVN EAE et al. FSHD associated DNA rearrangements are due to deletions of integral copies of a 3.2 kb tandemly repeated unit. Hum Mol Genet 1993;2:2037-42.
4. WINOKUR ST, BENGTSSON U, FEDDERSEN J et al. The DNA rearrangement associated with facioscapulohumeral muscular dystrophy involves a heterochromatin-associated repetitive element: implications for a role of chromatin structure in the pathogenesis of the disease. Chromosome Res 1994;2:225-34.
5. LEE JH, GOTO K, MATSUDA C, ARAHATA K. Characterization of a tandemly repeated 3.3-kb KpnI unit in the facioscapulohumeral muscular dystrophy (FSHD) gene region on chromosome 4q35. Muscle Nerve 1995;2:S6-13.
6. SANDRI M, EL MESLEMANI AH, SANDRI C et al. Caspase 3 expression correlates with skeletal muscle apoptosis in Duchenne and facioscapulo human muscular dystrophy. A potential target for pharmacological treatment? J Neuropathol Exp Neurol 2001;60:302-12.
7. WINOKUR ST, BARRET K, MARTIN JH et al. Facioscapulohumeral muscular dystrophy (FSHD) myoblasts demonstrate increased susceptibility to oxidative stress. Neuromuscul Disord 2003;13:322-33.
8. WINOKUR ST, CHEN YW, MASNY PS et al. Expression profiling of FSHD muscle supports a defect in specific stages of myogenic differentiation. Hum Mol Genet 2003;12:2895-907.
9. CHENIVESSE-LAOUDJ D, CARNAC G, BISBAL C et al. Increased levels of adenine nucleotide translocator 1 protein and response to oxidative stress are early events in facioscapulohumeral muscular dystrophy muscle. J Mol Med 2005;83:216-24.
10. GABELLINI D, GREEN MR, TUPLER R. Inappropriate gene activation in FSHD: a repressor complex binds a chromosomal repeat deleted in dystrophic muscle. Cell 2002;110:339-48.
11. JIANG G, YANG F, VAN OVERVELD PGM, VEDANARAYANAN V, VAN DER MAAREL S, EHRLICH M. Testing the position-effect variegation hypothesis for facioscapulohumeral muscular dystrophy by analysis of histone modification and gene expression in subtelomeric 4q. Hum Mol Genet 2003;12:2909-21.
12. GABELLINI D, D'ANTONA G, MOGGIO M et al. Facioscapulohumeral muscular dystrophy in mice overexpressing FRG1. Nature 2006;439:973-7.
13. ZHOU LZH, JOHNSON AP, RANDO TA. NF-κB and AP-1 mediate transcriptional responses to oxidative stress in skeletal muscle cells. Free Radic Biol Med 2001;31:1405-16.
14. MURPHY ME, KEHRER JP. Oxidative stress and muscular dystrophy. Chem Biol Interact 1989;69:101-73.
15. CATANI MV, SAVINI I, DURANTI G et al. Nuclear factor κB and activating protein 1 are involved in differentiation-related resistance to oxidative stress in skeletal muscle cells. Free Radic Biol Med 2004;37:1024-36.
16. SUN Y, OBERLEY LW. Redox regulation of transcriptional activators. Free Radic Biol Med 1996;21:335-48.
17. MONICI MC, AGUENNOUZ M, MAZZEO A, MESSINA C, VITA G. Activation of nuclear factor-kappaB in inflammatory myopathies and Duchenne muscular dystrophy. Neurology 2003;60:993-7.
18. YAN SD, STERN D, SCHMIDT AM. What's the RAGE? The receptor for advanced glycation end products (RAGE) and the dark side of glucose. Eur J Clin Invest 1997;27:179-81.
19. SCHMIDT AM, YAN SD, YAN SF, STERN DM. The multiligand receptor RAGE as a progression factor amplifying immune and inflammatory responses. J Clin Invest 2001;108:949-55.
20. CHAVAKIS T, BIERHAUS A, NAWROTH PP. RAGE (receptor for advanced glycation end products): a central player in the inflammatory response. Microbes Infect 2004;6:1219-25.
21. WAUTIER MP, CHAPPEY O, CORDA S, STERN DM, SCHMIDT AM, WAUTIER JL. Activation of NAPDH oxidase by AGE links oxidant stress to altered gene expression via RAGE. Am J Physiol Endocrinol Metab 2001;280:E685-94.
22. BUCCIARELLI LG, WENDT T, RONG L et al. RAGE is a multiligand receptor of the immunoglobulin superfamily: implications for homeostasis and chronic disease. Cell Moll Life Sci 2002;59:1117-28.
23. BIERHAUS A, SCHIEKOFER S, SCHWANINGER MD et al. Diabetes-associated sustained activation of the transcription factor nuclear factor-kappaB. Diabetes 2001;50:2792-808.
24. HASLBECK KM, BIERHAUS A, SCHLIECHER E et al. Receptor for advanced glycation endproduct (RAGE)- mediated nuclear factor-κB activation in vasculitic neuropathy. Muscle Nerve 2004;29:853-60.
25. HASLBECK KM, FRIESS U, SCHLIECHER ED et al. The RAGE pathway in inflammatory myopathies and limb girdle muscular dystrophy. Acta Neuropathol 2005;110:247-54.
26. ZAMORA M, MERONO C, VINAS O, MAMPEL T, Recruitment of NF-κB into mitochondria is involved in adenine nucleotide translocase 1 (ANT1)-induced apoptosis. J Biol Chem 2004;279:38415-23.
27. VOLLGRAF U, WEGNER M, RICHTER-L ANDSBERG C. Activation of AP-1 and nuclear factor-κB transcription factors in involved in hydrogen peroxide-induced apoptotic cell death of oligodendrocytes. J Neurochem 1999;73:2501-9.